Profound Medical Sees Q3 Sales $9.800M-$10.000M vs $6.934M Est

Benzinga Newsdesk www.benzinga.com Positive 74.0%

Neg 0% Neu 0% Pos 74%

Profound Medical (NASDAQ:PROF) sees Q3 sales of $9.800 million-$10.000 million vs $6.934 million analyst estimate.

Comments

No comments yet. Be the first!